Document is current
Any future updates will be listed below
-
Authors
Torres Chavez, Alejandro
McKenna, Mary Kathryn
Canestrari, Emanuele
Dann, Christina T.
Ramos, Carlos A.
Lulla, Premal
Leen, Ann M.
Vera, Juan F.
Watanabe, Norihiro https://orcid.org/0000-0002-7678-0141
-
Funding
Funding for this research was provided by:
Cook Regentec (Sponsored Research Agreement)
- License Information
-
More Information
Article History
Received: 22 July 2019
Accepted: 5 November 2019
First Online: 28 November 2019
Ethics approval and consent to participate
: Collection of human peripheral blood mononuclear cells (PBMCs) were obtained from healthy donors and patients after informed consent on protocols approved by the Institutional Review Board (IRB) at Baylor College of Medicine (H-15152, H-27471, H-19384 and H-31970). Mice were housed and treated in accordance with Baylor College of Medicine Animal Husbandry and Institutional Animal Care and Use Committee guidelines (AN-5639).
: Not applicable.
: Emanuele Canestrari and Christina T. Dann are employees of Cook Regenetec. Ann M. Leen and Juan F. Vera are consultants and have ownership interests (including stock and patent) in Marker Therapeutics, Inc. and Allovir. The other authors declare that they have no competing interests.
